Physician profile
Justin Wayne Walker
NPI 1073742573
$8,650.62
in general payments reported to CMS, 2019-2025
25 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.39 · 2020: $74.41 · 2021: $2,276 · 2022: $340 · 2023: $46.90 · 2024: $5,569 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,788 · Travel and Lodging: $1,773 · Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,787.50 |
| Travel and Lodging | $1,772.70 |
| Food and Beverage | $1,338.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $3,063.03 | 2021-2025 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Peerless Surgical INC. | $1,628.33 | 2021 | |
| Stryker Corporation | $1,272.70 | 2024 | Gamma |
| Piedmont Plus Innovation | $1,228.00 | 2024-2025 | |
| Axogen | $496.59 | 2022-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Anika Therapeutics, INC. | $374.79 | 2021 | |
| Encore Medical, Lp | $99.93 | 2022 | |
| Smith+Nephew, INC. | $80.26 | 2022-2024 | Evos |
| Integra Lifesciences Corporation | $75.91 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $45.36 | 2022 | |
| Depuy Synthes Sales INC. | $30.05 | 2019 | |
| Heron Therapeutics, INC. | $24.42 | 2023 | Zynrelef |
| Arthrex, INC. | $24.00 | 2024 | |
| Zimvie INC. | $22.48 | 2023 | |
| Osteocentric Technologies, INC. | $21.31 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $21.01 | 2020 | |
| Medtronic, INC. | $20.43 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.99 | 2021 | |
| Endo Pharmaceuticals INC. | $17.46 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.53 | 2019 | |
| Horizon Therapeutics Plc | $14.81 | 2019 | |
| Kerecis Limited | $14.71 | 2021 | |
| Zimmer Biomet Holdings, INC. | $14.63 | 2020 | |
| Next Science LLC | $12.57 | 2021 | |
| Paragon 28, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.